
Catherine Serke Williams
Examiner (ID: 6974, Phone: (571)272-4970 , Office: P/3993 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3763, 3762, 3731, 3993 |
| Total Applications | 1016 |
| Issued Applications | 626 |
| Pending Applications | 245 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11025104
[patent_doc_number] => 20160222058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/131662
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10545
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131662
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131662 | BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME | Apr 17, 2016 | Abandoned |
Array
(
[id] => 12702274
[patent_doc_number] => 20180125924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => SUPRAMOLECULAR GLYCOSAMINOGLYCANS
[patent_app_type] => utility
[patent_app_number] => 15/566066
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566066 | Supramolecular gylcosaminoglycans | Apr 12, 2016 | Issued |
Array
(
[id] => 14454253
[patent_doc_number] => 10323078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 15/559984
[patent_app_country] => US
[patent_app_date] => 2016-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 18340
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559984 | Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases | Mar 20, 2016 | Issued |
Array
(
[id] => 15309659
[patent_doc_number] => 10519521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Method of preventing carbohydrate crystallization
[patent_app_type] => utility
[patent_app_number] => 15/067012
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 6516
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/067012 | Method of preventing carbohydrate crystallization | Mar 9, 2016 | Issued |
Array
(
[id] => 11129241
[patent_doc_number] => 20160326217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'Methods and Compositions Related to Cyclic Peptide Synthesis'
[patent_app_type] => utility
[patent_app_number] => 15/061723
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 38516
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061723 | Methods and Compositions Related to Cyclic Peptide Synthesis | Mar 3, 2016 | Abandoned |
Array
(
[id] => 10820418
[patent_doc_number] => 20160166582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'PROTEASOME INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/050502
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15815
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050502 | PROTEASOME INHIBITORS AND USES THEREOF | Feb 22, 2016 | Abandoned |
Array
(
[id] => 10978457
[patent_doc_number] => 20160175399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'IL-13 RECEPTOR BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/045557
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045557 | IL-13 receptor binding peptides | Feb 16, 2016 | Issued |
Array
(
[id] => 15663781
[patent_doc_number] => 10596095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Method for moisturizing skin using P-113 peptide
[patent_app_type] => utility
[patent_app_number] => 15/550030
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3993
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550030 | Method for moisturizing skin using P-113 peptide | Feb 3, 2016 | Issued |
Array
(
[id] => 12138230
[patent_doc_number] => 20180016313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/548580
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7774
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548580 | Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof | Feb 2, 2016 | Issued |
Array
(
[id] => 15604355
[patent_doc_number] => 10583218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Composite containing collagen and elastin as a dermal expander and tissue filler
[patent_app_type] => utility
[patent_app_number] => 15/012257
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 12318
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012257 | Composite containing collagen and elastin as a dermal expander and tissue filler | Jan 31, 2016 | Issued |
Array
(
[id] => 16696701
[patent_doc_number] => 10947282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Functionalized protein-based materials and their uses
[patent_app_type] => utility
[patent_app_number] => 15/544216
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3003
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544216 | Functionalized protein-based materials and their uses | Jan 19, 2016 | Issued |
Array
(
[id] => 11009750
[patent_doc_number] => 20160206703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/996800
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8793
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996800 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | Jan 14, 2016 | Abandoned |
Array
(
[id] => 11011284
[patent_doc_number] => 20160208237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 14/991823
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7995
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991823
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/991823 | Modifications of peptide compositions to increase stability and delivery efficiency | Jan 7, 2016 | Issued |
Array
(
[id] => 13714281
[patent_doc_number] => 20170368095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => MAGNESIUM-CONTAINING OXYTOCIN FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/541991
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541991
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541991 | Magnesium-containing oxytocin formulations and methods of use | Jan 6, 2016 | Issued |
Array
(
[id] => 10776584
[patent_doc_number] => 20160122740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 14/981981
[patent_app_country] => US
[patent_app_date] => 2015-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12324
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/981981 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION | Dec 28, 2015 | Abandoned |
Array
(
[id] => 16414510
[patent_doc_number] => 10822386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Insulin analogues with enhanced stability and reduced mitogenicity
[patent_app_type] => utility
[patent_app_number] => 15/539450
[patent_app_country] => US
[patent_app_date] => 2015-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9623
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539450 | Insulin analogues with enhanced stability and reduced mitogenicity | Dec 23, 2015 | Issued |
Array
(
[id] => 11798088
[patent_doc_number] => 09538779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Tube feed formulations and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 14/966800
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18674
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/966800 | Tube feed formulations and methods for using same | Dec 10, 2015 | Issued |
Array
(
[id] => 11025109
[patent_doc_number] => 20160222064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/960206
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 22026
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/960206 | HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE | Dec 3, 2015 | Abandoned |
Array
(
[id] => 15054845
[patent_doc_number] => 10457711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Dermatophagoides farinae protein
[patent_app_type] => utility
[patent_app_number] => 15/532256
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7006
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532256 | Dermatophagoides farinae protein | Nov 30, 2015 | Issued |
Array
(
[id] => 13237001
[patent_doc_number] => 10131691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Compositions and methods for specific regulation of pyruvate dehydrogenase kinase
[patent_app_type] => utility
[patent_app_number] => 14/943735
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 12237
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14943735
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/943735 | Compositions and methods for specific regulation of pyruvate dehydrogenase kinase | Nov 16, 2015 | Issued |